Evidence map›Paper›PMID 34667252›Full record

ArticleScientific reports2021

Radiologic-pathologic analysis of increased ethanol localization and ablative extent achieved by ethyl cellulose.

Erika Chelales, Robert Morhard, Corrine Nief, Brian Crouch, Jeffrey I Everitt, Alan Alper Sag, Nirmala Ramanujam

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Non-Thermal Liver Ablation: Existing and New Technology.Seminars in interventional radiology · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Erika Chelales *Department of Biomedical Engineering, Duke University, Durham, NC, USA. erika.chelales@duke.edu.
Robert Morhard *Department of Biomedical Engineering, Duke University, Durham, NC, USA.
Corrine NiefDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Brian CrouchDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Jeffrey I EverittDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Alan Alper SagDivision of Vascular and Interventional Radiology, Department of Radiology, Duke University Medical Center, Durham, NC, USA.
Nirmala RamanujamDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Duke University · USDuke Medical Center · USDuke University Hospital · US

Funding

Novel see and treat strategies for cervical cancer prevention in low-resource settingsR01CA239268 · NCI · DUKE UNIVERSITY · PI KATZ, DAVID FRANK, RAMANUJAM, NIRMALA · 2019 to 2023
$3.1M
Enhanced ethanol ablation as a surgical-alternative for head and neck cancer treatment in resource-limited settingsF31CA239623 · NCI · DUKE UNIVERSITY · PI MORHARD, ROBERT · 2019 to 2020
$51k
NCI NIH HHS F31 CA239623NCI NIH HHS R01 CA239268NIH HHS R01CA239268
6 · The paper itself

Abstract

Ethanol provides a rapid, low-cost ablative solution for liver tumors with a small technological footprint but suffers from uncontrolled diffusion in target tissue, limiting treatment precision and accuracy. Incorporating the gel-forming polymer ethyl cellulose to ethanol localizes the distribution. The purpose of this study was to establish a non-invasive methodology based on CT imaging to quantitatively determine the relationship between the delivery parameters of the EC-ethanol formulation, its distribution, and the corresponding necrotic volume. The relationship of radiodensity to ethanol concentration was characterized with water-ethanol surrogates. Ex vivo EC-ethanol ablations were performed to optimize the formulation (n = 6). In vivo ablations were performed to compare the optimal EC-ethanol formulation to pure ethanol (n = 6). Ablations were monitored with CT and ethanol distribution volume was quantified. Livers were removed, sectioned and stained with NADH-diaphorase to determine the ablative extent, and a detailed time-course histological study was performed to assess the wound healing process. CT imaging of ethanol-water surrogates demonstrated the ethanol concentration-radiodensity relationship is approximately linear. A concentration of 12% EC in ethanol created the largest distribution volume, more than eight-fold that of pure ethanol, ex vivo. In vivo, 12% EC-ethanol was superior to pure ethanol, yielding a distribution volume three-fold greater and an ablation zone six-fold greater than pure ethanol. Finally, a time course histological evaluation of the liver post-ablation with 12% EC-ethanol and pure ethanol revealed that while both induce coagulative necrosis and similar tissue responses at 1-4 weeks post-ablation, 12% EC-ethanol yielded a larger ablation zone. The current study demonstrates the suitability of CT imaging to determine distribution volume and concentration of ethanol in tissue. The distribution volume of EC-ethanol is nearly equivalent to the resultant necrotic volume and increases distribution and necrosis compared to pure ethanol.

Indexed as

AnimalsCatheter AblationCelluloseEthanolFemaleLiverLiver NeoplasmsMaleModels, AnimalNecrosisRatsRats, Inbred F344CelluloseEthanolethyl cellulose

Identifiers

PMID34667252
PMCPMC8526742
OpenAlexW3118383251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.